Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
At least 73 injured after Houthi rebels attack Saudi civilian and energy facilities
Nepal rescue focused on workers trapped in three tunnels
Indonesia reopens Jakarta airport, four others after Anak Krakatau ash clears
Russia hits Kyiv after brief pause for US envoys' visit, killing two
Kenya offers temporary amnesty to undocumented East Africans amid crackdown fears
